Try our Advanced Search for more refined results
Zachary Silbersher, et al v. Dr. Falk Pharma GmbH, et al
Case Number:
20-16256
Court:
Nature of Suit:
Companies
- Adamas Pharmaceuticals Inc.
- Bausch Health Cos. Inc.
- BTG International Inc.
- BTG PLC
- Johnson & Johnson
- Salix Pharmaceuticals, Ltd.
- Taxpayers Against Fraud Education Fund
Government Agencies
- Commonwealth of Massachusetts
- State of Indiana
- State of Maryland
- State of Michigan
- State of Nevada
- State of Tennessee
- U.S. District Court for the District of Columbia
Sectors & Industries:
-
June 10, 2022
9th Circ. Mulls If Valid Patents Moot FCA Suit Against Bausch
A Ninth Circuit judge considering whistleblower allegations that Bausch Health fraudulently obtained a patent to prolong its monopoly on colitis drug Apriso pressed the plaintiff's attorney Friday on whether other valid patents also protected the drug, commenting, "If that's the case, then you don't have a False Claims Act claim."
-
October 22, 2020
IP Atty Asks 9th Circ. To Revive Bausch Whistleblower Suit
An intellectual property attorney who brought a whistleblower False Claims Act suit against Bausch Health alleging it fraudulently obtained a patent to prolong its monopoly on ulcerative colitis treatment Apriso told the Ninth Circuit that a California federal judge wrongly tossed the suit.